Yu Qian
Director, Cmc Cell Therapies @ Takeda
About Yu Qian
Yu Qian serves as the Director of CMC Cell Therapies at Takeda, where he has worked since 2024. He has a strong academic background in Cancer Biology and Immunology from Harvard Medical School and extensive experience in both research and industry, including previous roles at Takeda and Cipher Gene LLC.